"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
TO ARTICLE
METRICS

Original article
peer-reviewed

Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer: A Ten-Year Analysis


Total Article Reads

Article reads consist of online article views and PDF downloads. Cureus data is delayed by 24 hours and PMC data is delayed by approximately one month.

Total Article Reads Cureus PMC
5,931 Article Views 1,516 3,175
PDF Downloads 467 773
Total Article Reads Cureus PMC
5,931 Article Views 1,516 3,175
PDF Downloads 467 773
Total Article Reads
5,931
Cureus PMC
Article Views 1,516 3,175
PDF Downloads 467 773

Article Reads by Date

Hover your cursor over a specific day or month to see the corresponding online article views and PDF downloads. Cureus data is delayed by 24 hours and PMC data is delayed by approximately one month.

Cureus Article Reads

Loading...

Cumulative Cureus and PMC Article Reads

Loading...

Article Reads by Country

Hover your cursor over a country to see the number of online article views and PDF downloads from Cureus only.
Note: PMC does not share location data and not all Cureus reads are included below as location data is not available for all IP addresses.


Rank Country Views Percentage

Article Reads by U.S. States

Hover your cursor over a state to see the number of online article views and PDF downloads from Cureus only.
Note: PMC does not share location data and not all Cureus reads are included below as location data is not available for all IP addresses.


Rank State Views Percentage

Citations

Citation index reporting varies. Crossref citations are listed below and Google Scholar citations can be seen by clicking the corresponding button.

Google Scholar  
Crossref Citations (18)
  1. Serra, M., De Martino, F., Savino, F., D’Alesio, V., Arrichiello, C., Quarto, M., Loffredo, F., Di Franco, R., Borzillo, V., Muto, M., Ametrano, G., & Muto, P. (2022). SBRT for Localized Prostate Cancer: CyberKnife vs. VMAT-FFF, a Dosimetric Study. Life, 12(5), 711. https://doi.org/10.3390/life12050711 doi:10.3390/life12050711.
  2. Borowicz, D. M., Skrobała, A., Kruszyna-Mochalska, M., & Malicki, J. (2022). Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer? Radiology and Oncology, 0(0). https://doi.org/10.2478/raon-2022-0010 doi:10.2478/raon-2022-0010.
  3. Behmueller, M., Tselis, N., Zamboglou, N., Zoga, E., Baltas, D., Rödel, C., & Chatzikonstantinou, G. (2021). High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.770959 doi:10.3389/fonc.2021.770959.
  4. Altundal, Y., Cifter, F., Mu, G., Lee, J., Wu, E. J., Yeung, V., & Katz, A. (2020). Prostate Stereotactic Body Radiation Therapy With Halcyon 2.0: Treatment Plans Comparison Based on RTOG 0938 Protocol. Cureus. https://doi.org/10.7759/cureus.11660 doi:10.7759/cureus.11660.
  5. Yamazaki, H., Suzuki, G., Aibe, N., Shimizu, D., Kimoto, T., Masui, K., … Okabe, H. (2021). Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer. Cancers, 14(1), 195. doi:10.3390/cancers14010195.
  6. Blacksburg, S. R., Fuller, D. B., & Haas, J. A. (2020). Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer. Frontiers in Oncology, 10. doi:10.3389/fonc.2020.627686.
  7. Hwang, M. E., Mayeda, M., Liz, M., Goode-Marshall, B., Gonzalez, L., Elliston, C. D., … Deutsch, I. (2019). Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes. Radiation Oncology, 14(1). doi:10.1186/s13014-019-1346-5.
  8. Marvaso, G., Riva, G., Ciardo, D., Gandini, S., Fodor, C., Zerini, D., … Jereczek-Fossa, B. A. (2018). “Give me five” ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach. Medical Oncology, 35(6). doi:10.1007/s12032-018-1155-y.
  9. Vuolukka, K., Auvinen, P., Tiainen, E., Palmgren, J.-E., Heikkilä, J., Seppälä, J., … Kataja, V. (2020). Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results. Radiation Oncology, 15(1). doi:10.1186/s13014-020-01608-1.
  10. Nezhat, C., Vang, N., Vu, M., Grossman, J., Skinner, J., Robinson, K., … Gibbs, I. C. (2020). A Novel Approach for Treatment of Uterine Fibroids: Stereotactic Radiosurgery as a Proposed Treatment Modality. Current Obstetrics and Gynecology Reports, 9(1), 1–6. doi:10.1007/s13669-020-00277-x.
  11. Mańczak, A., & Milecki, P. (2020). Tolerancja ultrahipofrakcjonowanej radioterapii metodą SBRT raka stercza przy użyciu aparatu Cyberknife. Letters in Oncology Science, 17(1), 29–36. doi:10.21641/los.2020.17.1.168.
  12. Rigo, M., Mazzola, R., Napoli, G., Giaj-Levra, N., Figlia, V., Nicosia, L., … Alongi, F. (2020). Post-HIFU locally relapsed prostate cancer: high-dose salvage radiotherapy guided by molecular imaging. La Radiologia Medica. doi:10.1007/s11547-020-01148-4.
  13. Alayed, Y., Quon, H., Ong, A., Cheung, P., Chu, W., Chung, H., … Loblaw, A. (2020). Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT). Radiotherapy and Oncology, 149, 8–13. doi:10.1016/j.radonc.2020.04.039.
  14. De Muinck Keizer, D. M., Kerkmeijer, L. G. W., Maspero, M., Andreychenko, A., van der Voort van Zyp, J. R. N., van den Berg, C. A. T., … de Boer, J. C. J. (2019). Soft-tissue prostate intrafraction motion tracking in 3D cine-MR for MR-guided radiotherapy. Physics in Medicine & Biology, 64(23), 235008. doi:10.1088/1361-6560/ab5539.
  15. Alayed, Y., Davidson, M., Quon, H., Cheung, P., Chu, W., Chung, H. T., … Loblaw, A. (2020). Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy. Radiotherapy and Oncology, 144, 135–140. doi:10.1016/j.radonc.2019.11.017.
  16. Alayed, Y., Cheung, P., Chu, W., Chung, H., Davidson, M., Ravi, A., … Loblaw, A. (2019). Two StereoTactic ablative radiotherapy treatments for localized prostate cancer (2STAR): Results from a prospective clinical trial. Radiotherapy and Oncology, 135, 86–90. doi:10.1016/j.radonc.2019.03.002.
  17. Alayed, Y., Quon, H., Cheung, P., Chu, W., Chung, H. T., Vesprini, D., … Loblaw, A. (2019). Two versus five stereotactic ablative radiotherapy treatments for localized prostate cancer: A quality of life analysis of two prospective clinical trials. Radiotherapy and Oncology, 140, 105–109. doi:10.1016/j.radonc.2019.06.018.
  18. Alayed, Y., Cheung, P., Pang, G., Mamedov, A., D’Alimonte, L., Deabreu, A., … Loblaw, D. A. (2018). Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials. Radiotherapy and Oncology, 127(2), 213–218. doi:10.1016/j.radonc.2018.03.005.

Article Research Metrics

We’ve partnered with Plum Analytics to track and display research metrics for each article. (All data provided by PlumX Metrics.) Click here to learn more about Plum Analytics.